Eurocor bags fresh orders from Brazil, Egypt

 
 
Order Book crosses Rs 41 crore
 
 
Bangalore, May 23rd, 06: EuroCOR GmBH, the wholly owned subsidiary of Opto Circuits (India) Ltd (OCI), India’s leading manufacturer of healthcare equipments, has signed a distribution agreement with a large distributor in Brazil to cover Latin American markets for marketing its blockbuster drug eluting stent ‘TAXCOR’. The deal is worth over Rs 13.5 crore. The company has also bagged an additional order from Egypt for Rs 1.30 crore. With these, the total order’s booked during the month total Rs. 41.8 crore.

The landmark deal to cover these new markets was signed at the Paris Course on Revascularization (PCR) in France. PCR is the largest Convention for Interventional cardiologists, outside the United States. Eurocor GmBH had recently participated in PCR to showcase its Stenting products.

Highlighting the significance of EuroCOR’s global strategy, Vinod Ramnani, Chairman & Managing Director, OCI said, “Our entry into Brazil is a stepping stone towards becoming a dominant player in the Latin American markets. There is huge potential in these markets and we are in talks with distributors in Europe and the Far East. The global potential is expected to be around US $ 10 billion by 2008 and we are expanding geographically to capitalize on the market potential.”

Clinical data presentation by eminent cardiologists from Malaysia had brought in encouraging reviews from distributors in Europe and the Far Eastern countries. In the second week of July ’06, the company will also be participating in the largest South American Interventional Cardiology Show along with its Brazilian distributor.

EuroCOR’s distributors were also informed about its new products, namely, Guide Wires & Guiding Catheters; these would be introduced shortly. This will further enhance the company’s product pipeline.

 
 
 
  About Opto Circuits (India) Ltd.

Opto Circuits (India) Ltd. (OCIL) (BSE Code: 532391; NSE Symbol: OPTOCIRCUI) is a leading manufacturer of healthcare equipments in India. OCIL’s product profile includes sensors, probes, pulse oxymeters, patient monitoring systems and digital thermometers. In 2001, OCIL acquired 60% stake in Advanced Micronic Devices to market its equipments in India. OEMs contribute 80% of sales while MediAid (100% US-based subsidiary) contributes the balance. MediAid came into existence with the acquisition of the patient monitoring division of Palco Labs, US, in end-2003, and now markets OCIL’s products in the US markets directly. OCIL acquired EuroCOR GmbH (manufacturer of Cardiac and Peripheral Stents of various types, including Drug Eluting Coronary Stents used in Critical Cardiac Care) of Bonn, Germany in January 2006. Visit us at www.optoindia.com

 
 
 
  For further details on this release, please contact:  
 
Vaishali Tikotkar
Opto Circuits, Bangalore
+91 80 28521040 / 41 / 42
Rajiv Naidu / Shalaka Parab
Adfactors PR Pvt. Ltd., Mumbai
+91 22 22813565
 
 
     
Copyright © reserved for Opto Circuits India Limited (OCI). Site designed & maintained by Adsin Media Pvt. Ltd